Breast Cancer Research leads in semipostal sales
The Breast Cancer Research semipostal stamp has raised more than $80 million since it was issued in July 1988.
The United States Breast Cancer Research semipostal stamp (Scott B1) remains the best selling U.S. semipostal stamp, according to new sales figures released by the U.S. Postal Service.
Sales for the Breast Cancer Research stamp were $775,402.20 for December 2014, raising $142,157.07 in surcharges. This brings the total raised for this semipostal stamp to $80,147,680.10 since it was issued July 29, 1998.
The funds raised above the first-class letter rate of the stamp, currently 11¢ per stamp, are transferred to the National Institutes of Health and the Medical Research Program at the Department of Defense.
Sales for the Save Vanishing Species stamp (Scott B4), which recently resumed sales, were $123,222.60 for December, raising $22,590.81 in surcharges.
This brings the total raised for Multinational Species Conservation Funds to $2,616,103.60 since the Save Vanishing Species semipostal stamp was issued Sept. 20, 2011.
MORE RELATED ARTICLES
US StampsAug 12, 2022, 12 PM
Postal UpdatesAug 11, 2022, 6 PM
World StampsAug 11, 2022, 3 PM
Postal UpdatesAug 11, 2022, 2 PM